AP
Agios Pharm
🇺🇸XNAS.AGIOUnited StatesHealthcare
$33.49USDup +0.68 (+2.07%)OpenDelayed5:57 PM
Price$33.49+0.68 (+2.07%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US00847X1046
- CUSIP
- 00847X104
Company
- Employees
- 539
- Headquarters
- Cambridge, United States
- Website
- https://www.agios.com
- CEO
- Mr. Brian M. Goff M.B.A.
Market
- Shares outstanding
- 59.7M
- Market cap
- $2B
Key dates
- Next earnings
- Oct 29, 2026
Highlights
- Market cap
- $1.96B
- EPS LTM
- -$6.91
- P/E LTM
- -5.44
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $98.34M+140.58%up year on year
- Net income
- -$411.29M-163.27%down year on year
- Gross margin
- 87.92%+7.25%up year on year
- Free cash flow
- -$365.25M+10.7%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.